Travere Therapeutics prices $125M equity offering
- Travere Therapeutics (NASDAQ:TVTX) priced an underwritten public offering of ~7.81M shares at a price to the public of $16.00 per share.
- The gross proceeds from the offering are expected to be $125M.
- The offering is expected to close on November 12, 2024.
- Underwriters have a 30-day option to purchase up to an additional 1.17M shares.
- The stock price dropped 2.3% on Friday during pre-market hours of trading.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。